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The kidney androgen-regulated protein (KAP)
gene is exclusively expressed in proximal tubules
of mouse kidney and in the uterus of pregnant
females before they give birth. It displays an ex-
quisite and differential regulation of expression
by steroid and thyroid hormones (THs) in differ-
ent proximal tubule segments. Whereas the pars
recta (PR cells) responds to thyroid and sexual
hormones, the pars convoluta (PCT cells) repre-
sents a truly androgen-dependent compartment
because expression occurs only in the presence
of androgens and functional androgen receptors.
Nevertheless, different hypothyroidism models
have indicated that TH might also contribute to
the androgenic response in PCT cells. In the
present study, we aimed to determine the molec-
ular mechanisms that ultimately control KAP ex-
pression in these cells. Using several genetically
deficient mouse models and different pharmaco-
logic and hormonal treatments, we determined
that thyroid and GH modulate CCAAT/enhancer
binding protein  and  levels that, in turn, con-
trol KAP expression in PCT cells in a develop-
mentally dependent manner. We demonstrated
that these factors bind to sites in the proximal
KAP promoter, thereby collaborating with andro-
gens for full KAP expression. Finally, we propose
that TH and GH, acting through CCAAT/enhancer
binding protein, may constitute a general regu-
latory mechanism of androgen-dependent genes
in mouse kidney. (Molecular Endocrinology 20:
389–404, 2006)
THE KIDNEY ANDROGEN-regulated protein (KAP)was originally identified by in vitro translation of male
mouse kidney mRNA (1). It constitutes the most abun-
dant (4% of total polyadenylated mRNA) and specific
gene expressed in proximal renal tubule cells, as shown
by SAGE (serial analysis of gene expression) (2), SADE (a
sage adaptation for down-sized extracts) (3), and ex-
pression profiling of active genes (4). Cell specificity and
the complex regulatory mechanisms involved in KAP
mRNA expression (5), together with KAP mRNA relative
abundance, point to a significant role for its encoded
protein. Analyses of both nucleotide and peptide se-
quences failed to reveal significant homology with other
genes, expressed sequence tag or proteins, or with
known structural or functional domains. The absence of
known functional domains greatly reduced experimental
approaches to elucidating KAP function, prompting us to
perform a yeast two-hybrid assay that showed that KAP
interacts with CsA binding protein CyPB, CsA adminis-
tration reduces KAP steady-state levels in mouse kidney,
and KAP overexpression reduces CsA toxicity in cul-
tured proximal tubule cells. Thus, our data indicate a
functional KAP, CyPB, and CsA-mediated toxicity rela-
tionship in kidney (6).
Our laboratory has been interested in understanding
the regulation of KAP mRNA that displays a tissue- and
cell-specific expression restricted to epithelial cells of
proximal convoluted tubules in mouse kidney (7). This
gene is subjected to strict and exquisite regulation by
thyroid and sexual steroid hormones in different seg-
ments of proximal tubules. In vivo studies have shown
that S3 cells (pars recta), which correspond to the outer
stripe of the outer medulla, express the gene in the
presence of thyroid hormone (TH/T3) (8), and are also
sensitive to androgen and estrogen action (9). Females
and castrated males express the gene exclusively in S3
cells (7). Segments S2 and S1 (pars convoluta), which
correspond to the cortical part of the kidney, express the
gene only in the presence of androgens and a functional
androgen receptor (AR); therefore, females, castrated
males or AR-deficient mice of the Tfm/Y strain are
negative for cortical expression of KAP mRNA (10).
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Accordingly, androgen replacement in castrated
males or treatment of females with testosterone in-
duces expression in the cortical segments of the
tubule (7). We also observed that male mice genet-
ically deficient for TH (hyt/hyt strain) exhibit lower
cortical KAP mRNA expression than wild-type con-
trol males and that exogenous T3 injection prompts
full expression recovery (8). Moreover, treatment of
adult male control mice with potassium perchlorate
(KClO4), which reversibly competes for entry of io-
dine into the thyroid gland, resulting in severe phar-
macological hypothyroidism, produces the same ef-
fect (11). These results, and the fact that simultaneous
treatment of KClO4 and TH restored KAP expression in
the cortex, strongly suggested the involvement of TH in
the androgenic control of KAP mRNA expression in cor-
tical tubule segments. Presence of KClO4 did not modify
plasma testosterone levels or expression of the andro-
gen receptor itself (11). More remarkably, animals born to
mothers exposed to KClO4 during pregnancy and after
delivery were unable to express KAP mRNA in any com-
partment of the kidney, including the cortical convoluted
segments, even at postnatal d 90 (11). Because T3 is
unable to induce cortical expression in castrated males
(8), we concluded that androgens are necessary but not
sufficient to induce KAP expression in the cortex and that
presence of TH is also required.
In the present work, we aimed to gain further insight
into the molecular mechanisms that control TH involve-
ment in the developmental sexual dimorphic pattern of
KAP expression in mouse kidney by identifying the mo-
lecular elements that collaborate with androgens in the
cortical expression of the KAP gene. To this end, in vivo
and in vitro studies were conducted using the proximal
tubule-derived cell line PKSV-PCT, originally developed
in Dr. Vandewalle’s laboratory (12, 13) that, together with
the PKSV-PR, are alone in supporting androgen-depen-
dent expression of kidney-specific genes in an isolated
cell system (14). For years, the lack of an appropriate cell
line has hampered detailed characterization of the mo-
lecular elements mediating androgen-responsive gene
expression in the kidney. Our studies proved the hor-
mone-specific regulation of the KAP gene promoter in
these cultured mouse renal proximal tubule-derived cells
(15), by demonstrating that these cell lines constitute an
excellent and valuable ex vivo model for analyzing the
mechanisms and further characterizing the molecular
elements controlling the intricate and complex regulation
of KAP gene in mouse kidney.
RESULTS
Postnatal TH Requirement and GH Involvement in
the Androgen-Dependent Expression of the KAP
Gene in Kidney Cortex
Previous work showed that male mice exposed to
KClO4 from d 10 of gestation until being euthanized
were not expressing the KAP gene, even at postnatal
d 90, and related this effect to the absence of TH (11).
To assess whether TH played a role during prenatal
development, after birth or in both time periods, four
different groups of animals were studied by in situ
hybridization using specific antisense cRNA probes for
KAP mRNA. Results showed that male and female
control water-treated mice (group 1) and animals
treated with 1% KClO4 for the entire experiment
(group 4) expressed the gene in the expected manner,
as described (7, 11) (Fig. 1A). Results obtained in
groups 2 and 3 showed that only animals treated with
1% KClO4 during the gestational period (group 2) were
able to express the gene like those in the control
water-treated group.
Average size and weight of mice in each group
showed significant differences for animals exposed to
1% KClO4 (Fig. 1A, including table). For those under
permanent treatment (group 4), weight and size were
2.5- and 1.5-fold lower, respectively, than in control
animals (group 1), which suggests that an associated
GH deficiency-related event to the strong hypothy-
roidism caused by the goitrogen treatment. As for KAP
expression, effects on weight and size were clearer in
postnatal treated mice (group 3) than in those exposed
to treatment before birth (group 2). These results indi-
cated that, at least in part, GH could be involved in
KAP cortical expression. From previous work, we
knew that when TH deficiency occurs in the absence
of a dwarf-associated phenotype, i.e. in the hyt/hyt
mouse model, cortical expression is diminished but
not abolished (8); therefore, we hypothesized that, the
combined absence of GH and TH would likely result
in lack of KAP expression. To demonstrate this hy-
pothesis, we used two genetically deficient mouse
models, GH and prolactin (PRL)-deficient little mice
and pituitary transcription factor-1 (Pit-1)-deficient
C3H/HeJ dwarf mice from The Jackson Laboratory
(Bar Harbor, ME). The specific pituitary transcription
factor Pit-1 deficiency led to absence of GH, PRL,
and TSH in the C3H/HeJ mice, resulting in a com-
bined hypothyroid and dwarf phenotype. Results
from this experiment showed that deficiency of GH
and PRL does not compromise androgen-depen-
dent cortical KAP expression (little) as does com-
bined absence of GH, PRL, and TSH (Jackson dwarf)
(Fig. 1B).
Goitrogen-treated male mice were injected with
T3, GH, or both at the same time, from postnatal d
7–21, to further verify the involvement of these hor-
mones in the pharmacological model and to dem-
onstrate that the results obtained were not indirectly
related to putative nephrotoxic effects of KClO4 in
the kidney. In situ hybridization experiments showed
that T3 administration restored KAP expression in
both kidney compartments (outer medulla and cor-
tex). This effect was enhanced by coinjection of GH,
although GH administration alone produced no ef-
fect (Fig. 1C).
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Fig. 1. TH and GH Influence KAP mRNA Expression in Kidney Cortex
A, Effects of pre/postnatal TH deprivation on KAP gene expression. Frozen male and female kidney sections from animals
exposed permanently to regular tap water (Group 1), those treated with KClO4 1% in drinking water from d 10 of gestation until
birth (Group 2), those with KClO4 1% from birth until euthanized at postnatal d 40 (Group 3) or those exposed to KClO4 1% from
d 10 of gestation until euthanized at postnatal d 40 (Group 4) were hybridized with strand-specific 35S-KAP3 antisense cRNA. The
magnification chosen for these images (40) permitted visualization of the three major compartments of the kidney (c, cortex; o,
outer medulla; i, inner medulla). At right, the table displays average weight and size of the animals belonging to each group and
classified by sex. B, KAP gene expression in lit/lit and Jackson dw/dw mice. Frozen kidney sections from control (left panel),
homozygous lit/lit (middle panel), and Jackson dw/dw (right panel) male mice were hybridized with strand-specific 35S-KAP
(KAP3) cRNA as previously described. The left panel corresponds to a kidney section from a normal male of the C57BL/6 Lit/
genetic background. Hybridization of frozen sections from a normal male of the C3H/HeJ dwj/ strain yielded similar results (data
not shown). C, KAP gene expression in male mice exposed to 1% KClO4 and treated with T3- and/or GH. Frozen kidney sections
from C/57BL6 untreated control males (left upper panel), potassium perchlorate 1%-treated males from birth until euthanized at
postnatal d 40 (middle upper panel), or similar mice treated with TH (right upper panel), GH (left lower panel), and TH plus GH (right
lower panel) from postnatal d 7–21 were hybridized with strand-specific 35S-KAP (KAP3) cRNA as previously described.
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Fig. 2. Punctual Presence of TH Triggers KAP Expression in Cortex
A, Restoration of TH synthesis on goitrogen removal at different postnatal time points permits recovery of KAP gene expression
in potassium perchlorate-treated male mice. Frozen kidney sections from C57BL/6 potassium perchlorate-treated males from
birth until euthanized at postnatal d 40 (control; upper left panel) were hybridized with strand-specific 35S-KAP (KAP3) cRNA, as
previously described and compared with similar animals exposed to tap water from indicated time points (see figure) and further
exposed to perchlorate in drinking water until euthanized. In situ hybridization of nontreated control males from birth until
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Punctual Presence of T3 Is Sufficient to Trigger
KAP Expression
We next aimed to investigate at what time points in
postnatal development TH was required to trigger
KAP expression. To avoid stressing the animals with
daily T3 injections, a different strategy was used
based on replacing 1% KClO4 containing water by
normal tap water during the time points studied.
Before proceeding with this novel approach, we
tested whether this treatment had equivalent effects
to T3 injection in animals exposed to 1% KClO4
during the same period of time. Results on KAP
expression when mice were euthanized (postnatal d
40) confirmed that both procedures had similar ef-
fects (data not shown); concomitantly, weights of
animals under both treatments were practically
identical: 13.31 g  0.1 for those exposed to T3 from
postnatal d 7–21 and 13.98 g  0.1 for those ex-
posed to tap water from postnatal d 7–21. Control
males had a weight of 19.7 g  0.1 vs. 8 g  0.1 of
those permanently exposed to 1% KClO4.
Once the procedure had been confirmed as effec-
tive, hypothyroid animals (potassium perchlorate-
treated males) were exposed to regular tap water for
different time periods (see Fig. 2A) and KAP mRNA
expression was compared with that of age- and
sex-matched animals exposed to tap water (non-
treated control male) or potassium perchlorate (con-
trol) at 40 d postnatally. Results showed in Fig. 2A,
indicated that the presence of T3 around postnatal d
12 and beyond facilitated KAP expression and that
48 h exposure to tap water seemed sufficient to
produce this effect. Female mice treated with tap
water from birth to d 14 were negative for KAP
expression in cortex at d 40 (Fig. 2B), whereas males
treated in the same manner exhibited KAP expres-
sion in this compartment. These results indicated
that only in males was the presence of TH after
postnatal d 12 required to trigger KAP expression in
cortex and that once this had occurred, the pres-
ence of TH was no longer required.
Expression of CCAAT/Enhancer Binding Protein
(c/EBP)  and  Genes under Different Hormonal
Conditions and Correlation with KAP Expression
in Mouse Kidney
Because TH was not able to induce KAP mRNA in the
cortex of castrated males (8), and because KAP prox-
imal promoter does not contain canonical TH receptor
binding sites, we proposed an indirect action of TH in
KAP expression. Among different possibilities, we first
explored whether other transcription factors under TH
control might be collaborating with androgens on KAP
regulation. Inspection of the KAP proximal promoter
indicated different putative transcription factor binding
sites, including several for the c/EBP family members,
at positions 457, 429, 110, and 66, from the
transcription initiation site (16). Because it had been
described that TH was regulating c/EBP and  gene
expression (17) and also because of the significance of
these transcription factors in development, we inves-
tigated their expression levels in mouse kidney, under
different hormonal conditions and correlated them
with those of KAP mRNA.
c/EBP and  levels in kidneys of male mice ex-
posed to 1% KClO4 or castration were assessed by
Western blot assays. Results clearly showed c/EBP
and  expression to be residual in 1% KClO4-treated
mice and levels of both factors to be reduced in cas-
trated males (Fig. 3A). Semiquantitative RT-PCR in the
same kidney samples revealed an almost undetect-
able expression of KAP mRNA in the presence of 1%
KClO4 and an obvious decrease in castrated males
(Fig. 3B), in agreement with previous in situ hybridiza-
tion results. Changes in KAP mRNA expression cor-
related well with c/EBP and b protein levels, thereby
indicating a possible functional relationship. To further
test this hypothesis, c/EBP and  protein levels were
determined in kidneys of potassium perchlorate-
treated males (controls), animals additionally given TH
from postnatal d 7–21 (7–21 d T3) and controls (non-
treated control males). Western blot assays indicated
that c/EBP and  were recovered in the TH-treated
males (Fig. 3C) and that KAP mRNA was also ex-
pressed under these conditions (Fig. 3D). In summary,
the clear correlation observed among hormonal status
of the animals, c/EBP and  levels and KAP mRNA
expression strongly suggests involvement of c/EBPs
in KAP gene expression.
Effects of c/EBP and  on KAP Promoter
Transcription in PCT3 Cells
PCT3 cells, derived from the parental PKSV-PCT, have
already shown their ability to support androgenic reg-
ulation of reporter gene constructs containing the kid-
ney-specific KAP promoter in transient transfection
assays (15). To further investigate the concept that
TH-dependent expression of KAP mRNA in cortical
segments of proximal tubules might relate to the pres-
ence of c/EBP and , transient transfection assays
using the 638 KAP proximal promoter fragment
euthanized has also been included (rightmost panel) (c, cortex; o, outer medulla; i, inner medulla). B, Differential KAP cortical
expression in potassium perchlorate-treated male and female mice, after postnatal d 14. Frozen kidney sections from C57BL/6
potassium perchlorate-treated male and female mice from birth until euthanized at postnatal d 40 (left upper and lower panels,
respectively) were hybridized with strand-specific 35S-KAP3 cRNA probes, as previously described, and compared with similar
animals exposed to tap water from birth until postnatal d 14, and to potassium perchlorate from d 15 until euthanized at d 40 (right
upper and lower panels).
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fused to chloramphenicol acetyl transferase reporter
gene (CAT) were performed (Fig. 4A). Experiments
were carried out in PCT3 cells under different hor-
monal treatments and in the presence or not of co-
transfected expression vectors for c/EBP and 
cDNAs.
Results indicated that c/EBP or c/EBP alone
(lanes 7 and 8, respectively) exhibited the same trans-
activation capacity as DHT in the presence of a trans-
fected functional androgen receptor (lane 3) on the
638 KAP promoter (3-fold) (Fig. 4A). When andro-
gens and androgen receptor were included together
with c/EBP,  or both, activity was around 5- to
6-fold higher (lanes 4–6, respectively). These results
indicated a role for c/EBP and  as well as an additive
effect of androgens and these transcription factors on
KAP gene transactivation.
Site-Directed Mutagenesis of Putative c/EBP
Binding Sites in the KAP Promoter
Site-directed mutagenesis was performed on the
224K and 638K KAP constructs fused to the luciferase
(LUC) reporter gene to further investigate whether the
putative c/EBP binding sites identified in the KAP pro-
moter were functionally relevant. The K224 construct
contains two putative sites, from66 to56 and from
110 to 101 from the transcriptional initiation site,
Fig. 3. c/EBP Levels Correlate with KAP mRNA Expression in Cortex
A, Effects of postnatal hypothyroidism and castration on c/EBP and c/EBP protein levels in mouse kidney. Western blot
assays were performed with nuclear (N) and cytosolic (C) extracts from kidneys of untreated control C57BL/6 male mice (control
male), mice treated with 1% KClO4 in drinking water from birth until euthanized at postnatal d 40 (KCl04 1% male) and castrated
mice (castrated male). Antibodies against c/EBP (p42) and c/EBP (p35/p38) were used as described in Material and Methods.
Specificity of the signals obtained with these antibodies was previously tested by incubation of each antibody with a 5-fold excess
of their specific peptide (sc-61 P for c/EBP and sc-150 P for , both from Santa Cruz Biotechnologies) (not shown). Blots
presented in the figure were performed with antibodies blocked with nonspecific peptides (M-20 for mouse gp130). Protein
loading was assessed by gel staining with Coomassie brilliant blue and indicated on the figure as loading control for c/EBP  and
 blots, respectively. B, Endogenous KAP mRNA expression levels in postnatal hypothyroid and castrated male mice. Endog-
enous KAP mRNA levels were measured by semiquantitative RT-PCR technique (see Materials and Methods for details) in extracts
obtained from the contralateral kidney of the same animals used for c/EBP protein detection (see text of Fig. 3A). The KAP/Cyp
A ratio is expressed as fold increase over basal level, as previously described (15). C, c/EBP  and  protein levels in hypothyroid
male mice treated postnatally with TH. The experimental procedure was the same as described in Fig. 3A. c/EBP and  levels
were determined in kidneys of 1% potassium perchlorate-treated males from birth until euthanized (40 d postnatal) (control), in
similar animals treated from postnatal d 7–21 with daily doses of TH (1.2 g) (7–21 T3-treated males) and both were compared
with naive male mice of the same age (nontreated control male). D, KAP mRNA levels on hypothyroid male mice treated
postnatally with TH. In situ hybridization in contralateral kidneys of the same animals used for c/EBP protein detection (see text
of panel C). Technical procedures were the same as those described in Fig. 1A. c, Cortex; o, outer medulla; i, inner medula.
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which were individually deleted and assayed by tran-
sient transfection in PCT3 cells. The same was done
within the K638 construct where sites 66 to 56,
110 to101,429 to420 and457 to448 were
individually deleted and tested (henceforth referred to
as: 66, 110, 429 and 457) (Fig. 5A). Although
results from these experiments indicated no signifi-
cance for any of the individually mutated sites (Fig.
5B), a second set of experiments revealed that the
simultaneous mutation of the 457 and 429 sites in
the K638 construct produced a strong decrease in
their transcriptional activity, which dropped approxi-
mately 35- to 40-fold, compared with that of the K638
control construct (Fig. 5C). c/EBP  or  cotransfec-
tion did not affect the transcriptional capacity of the
K638 double-mutated construct (Fig. 5C). Triple mu-
tated constructs, including the other two sites at po-
sitions 110 or 66, did not produce additional ef-
fects to those obtained with the double mutated
construct (Fig. 5C).
From the in vivo experiments, we concluded that TH
controls androgen-dependent cortical KAP gene ex-
pression through modulation of factors that might col-
laborate with androgens in the presence of a func-
tional AR. To determine whether the sites at positions
457 and 429 were affected by the absence of
steroid hormones in the culture media and/or the ab-
sence of the androgen receptor response element
(ARE), previously defined at position 39 on the KAP
promoter (15), transient transfection assays in com-
plete or steroid hormone-free media were performed.
Results (Fig. 5D, upper left panel) showed that muta-
tion of the ARE further decreased the relative activity
of the 457 and 429 mut K638 construct that went
from 40-fold to 100- to 150-fold. In the absence of
steroid hormones (Fig. 5D, right side of the upper
panel), the effects were comparable to mutation of the
ARE; no significant differences were observed be-
tween the K638(457–448, 429–420) or the
K638(457–448, 429–420, 39–35) construct, indi-
cating that androgens, acting through this androgen
receptor binding site, together with factors binding to
the 457 and 429 sites collaborated on the tran-
scriptional activity of the KAP promoter.
The transcriptional activity of the pGL3 basic vec-
tor was influenced neither by the presence of trans-
fected c/EBP expression vectors nor by the culture
conditions used (Fig. 5D, lower panels), which
proved that the effects observed were KAP pro-
moter dependent.
c/EBP  and  Bind to the 457 Box
All evidence found in the above-described experi-
ments, both in kidney and in PCT3 cells, pointed to
c/EBP and  as the putative transcription factors able
to control KAP gene expression in the presence of
androgens.
To reinforce this concept, gel retardation assays
were performed with oligonucleotides corresponding
to the 457 and 429 boxes, in the presence of nuclear
extracts obtained from kidneys or PCT3 cells. Results
(Fig. 6A) showed that there were nuclear factors in
PCT3 cells able to bind to these two boxes and, also,
Fig. 4. c/EBP Affects KAP Promoter Transactivation in PCT
Cells
A, Effects of androgens and c/EBP and  on the tran-
scriptional activity of the K638 promoter construct in PCT3
cells. Cultured mouse PCT3 cells were transfected with 2 g
of the K638 construct, in the presence of 0.5 g of cotrans-
fected human androgen receptor (AR) expression vector pS-
VAR0 (lanes 2–6) and treated for 48 h with vehicle (lanes 1, 2,
7, and 8) or with 106 M DHT (lanes 3–6) in steroid-free
medium. A total of 0.5 g of pMSV-c/EBP and PMSV-c/
EBP expression vectors, which contain the entire open
reading frame of rat c/EBP and mouse c/EBP (p35 LAP),
was also cotransfected to the same cells, either alone (lanes
7 and 8) or in different combinations that include cotransfec-
tion of AR and presence of DHT (lanes 4–6). Autoradiograms
of CAT assays measured in homogenates of transfected cells
are shown in the upper part of the figure. CAT activities were
adjusted according to the -galactosidase activity produced
by 2 g of transfected pCH110 plasmid. Bars indicate the
mean (SE) of fold induction of reporter activities over control
unstimulated, nonreceptor or c/EBPs-transfected cells (1)
for a minimum of three independent experiments. B, Outline
of the proximal KAP promoter. ARE and the four putative
C/EBP binding sequences positions on proximal KAP pro-
moter are shown.
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Fig. 5. Functional Analysis of Putative c/EBP Mutated Sites on the KAP Promoter
A, Set of the different mutated versions of the LUC K638 and K224 KAP promoter reporter constructs. Nucleotides deleted from
native sequences on the K224 and K638 promoter constructs were the following: positions 66–56 [K638/224 (66–56)]:
ACTGTGGAAA; 110–101 [K638/224 (110–101)]: CTTCCCCAAAC; 429–420 (K638/224 (429–420): CTCCAGCAAT; and 457–
448 [K638 (457–448)]: CTTTTGCAAT. B, Functional assays of single deletion of the putative c/EBP binding sites on the KAP
promoter. Functional activities of 1 g K224 or K638 (wild type) were tested on PCT3 cells and compared with 1 g of each
mutated construct. LUC activities were adjusted according to the Renilla LUC activity produced by 20 ng of transfected pRL-TK
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to a consensus wild-type (WT) c/EBP box, but not to a
mutant one (MUT). To determine the specificity of
these retarded band, competition experiments includ-
ing 30-fold excess of cold 457, 429, c/EBP WT, and
c/EBP MUT oligonucleotides were performed. Results
(Fig. 6B) showed that the retarded band on 457 box is
competed out by cold WT c/EBP or by the same 457
sequence, but not by the c/EBP MUT. Because box
429 was only competed by its own sequence, our
results suggested that the factor bound to the 457
sequence, but not that one bound to the 429 se-
quence, may belong to the c/EBP family. Next, we
aimed to identify the nature of this factor by perform-
ing supershift assays with antibodies against c/EBP 
and . As expected, the retarded band for the 429 box
was unaffected by the presence of the antibodies.
Anti-c/EBP, but not anti-c/EBP, produced a super-
shift of the 457 and c/EBP WT boxes (Fig. 6C). The
lack of c/EBP supershift could not be attributed to
absence of this isoform because its presence in the
PCT3 nuclear extract was determined by Western blot
analysis (not shown). Similar experiments performed
with male mouse kidney nuclear extracts produced
retarded bands for the 457 box that were competed by
c/EBPWT but not by c/EBPMUT (Fig. 6D). When using
these extracts, supershifts occurred with both anti-c/
EBP and anti-c/EBP antibodies (Fig. 6E) indicating
that, contrary to what occurs in PCT3 cells, both
c/EBP factors are able to bind to the 457 box in mouse
kidney extracts. Note that kidney extracts contain
c/EBPs from all their different cell types. Whether this
difference in binding ability to the 457 box is due to a
different cellular origin of the active c/EBP in whole
kidney (i.e. not necessarily coming from cortex cells) or
reflects an abnormal behavior of c/EBP of the PCT
cells is not known. The nature of the factor that binds
to the 429 box and the mechanisms that operate to
make c/EBP incompetent to bind to the 457 box in
PCT3 cells remain to be determined.
DISCUSSION
Although earlier in situ hybridization assays in mouse
kidney had clearly demonstrated that the presence of
androgens and functional androgen receptors were
instrumental and apparently sufficient for KAP gene
expression in cortical S1 and S2 segments of proximal
tubules (10), later studies revealed the important con-
tribution of TH to achieve a full androgen-dependent
cortical response in males (8).
Although TH involvement was established, striking
differences arose in KAP mRNA expression levels be-
tween congenital hypothyroid hyt/hyt adult males (8)
and adult mice exposed to potassium perchlorate
from d 10 of gestation until euthanized at postnatal d
90 (11). The hyt mice present primary hypothyroidism
related to the hyporesponsiveness of the thyroid gland
to TSH, which results in very low TH serum levels and
abnormally high TSH levels (18). Perchlorate inhibits
the transport of iodine into the thyroid in a competitive
and reversible manner, which results in a decrease of
TH production (T4 and T3) and an increase in TSH
production (19). In the past, we had determined T4 and
T3 concentrations in kidneys of hypothyroid mice (8,
11). Adult animals treated for 1 wk with KClO4 gave
values that ranged from 0.258–0.524 ng of T3 and from
0.734–1.119 ng of T4/g tissue. Although very difficult
because of their small size, congenital perchlorate-
treated mice were also analyzed and values of T3 and
T4 in kidney tissues ranged from 0.306–0.742 ng of T3
and from 0.643–2.260 ng of T4/g of tissue. Animals of
the hyt/hyt strain had values ranging from 0.548–0.974
ng of T3 and from 0.857–2.85 ng of T4/g of tissue. We
concluded that KClO4 treatment was effective to ren-
der the animals hypothyroid, with TH values being
even lower than those in the hyt/hyt mice. Untreated
control mice ranged from 1.3–2.4 or higher ng of T3/g
of tissue.
in the same sample. Fold induction over basal level of relative LUC activity for both constructs (K224, K638) was compared; results
are shown in panel B. Bars indicate the mean (SE) of fold induction of LUC activity over control nonmutated constructs (1), for
a minimum of three independent experiments. C, Functional assays of double and triple deletion of the putative c/EBP binding
sites on the KAP promoter. Functional activities of 1 g of K638 mutated constructs in two sites: K638 (457–448, 429–420) or in
three sites: K638 (457–448, 429–420, 110–101) and K638 (457–448, 429–420, 66–56) were tested in PCT3 cells and compared
with 1 g of K638 (wild type) following the same procedures as described in Fig. 5A. For each mutated construct, an additional
situation, which corresponds to cotransfection of 0.5 g of pMSV-c/EBP and PMSV-c/EBP expression vectors, was included.
Bars indicate the mean of fold induction of LUC activity over control nonmutated constructs (1), for a minimum of three
independent experiments. Error bars are not visible because values were too small to be depicted at this scale. D, Effects of
steroid hormone depletion and/or ARE mutation on transcriptional activity of the K638 (457–448, 429–420) construct. The K638
(457–448, 429–420) construct was additionally deleted at the identified functional androgen receptor site (ARE) at position39
from the transcription start site on the KAP promoter (15). The mutated ARE lacks the underlined sequence: 5-GGTACAGGAT-
GTATAAA-3 from positions 39 to 34. Functional activities of 1 g of K638 mutated constructs K638 (457–448, 429–420)
and K638 (457–448, 429–420, 39–34) were assayed in PCT3 cells and compared with 1 g of K638 (wild type), following the
same procedure as described in Fig. 5A. The experiment was conducted in complete medium that includes presence of steroid
hormones (left upper panel) or in steroid hormone-depleted media (right upper panel). For each mutated construct, an additional
situation corresponding to cotransfection of 0.5 g of pMSV-c/EBP and PMSV-c/EBP expression vectors was included. As a
control, 1 g of pGL3 basic vector was transfected or cotransfected with 0.5 g of pMSV-c/EBP and PMSV-c/EBP expression
vectors, in complete (left lower panel) or steroid-free media (right lower panel). Bars indicate the mean of fold induction of LUC
activity over control nonmutated constructs (1), for a minimum of three independent experiments. Error bars are not visible
because values were too small to be depicted at this scale.
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Fig. 6. Box 457 Binds c/EBP
A, EMSA of boxes 429 and 457. Five micrograms of nuclear extracts from PCT3 cells were incubated with 32P-labeled
oligonucleotide duplex containing sequences corresponding to box 457 (lane 8) and box 429 (lane 6) from the KAP proximal
promoter and analyzed by gel shift assay. 32P-labeled c/EBP consensus WT (lane 2) or c/EBP MUT sequences (lane 4), from Santa
Cruz Biotechnologies, were used as positive and negative binding controls, respectively. Lanes 1, 3, 5, and 7 are controls for free
DNA probe. The sequences for each probe are described in Materials and Methods. B, Competitive EMSA of boxes 429 and 457.
Specific protein binding by 32P-labeled oligonucleotide duplex probes c/EBP WT (lanes 1–5), box 429 (lanes 7–10) and box 457
(lanes 12–15), incubated with 5 g of nuclear extracts from PCT3 cells, was competed with 30-fold molar excess of cold
oligonucleotides, corresponding to c/EBP WT (lanes 2, 8, and 13), c/EBP MUT (lanes 4, 9, and 14), box 429 (lanes 5 and 10) and
box 457 (lanes 3 and 15) sequences, described in Fig. 6A. Band patterns with no competitor oligonucleotide added are also shown
in each case (lanes 1, 7, and 12). Lanes 6 and 11 are controls for free DNA probe. C, Supershift assays of complexes bound in
boxes 429 and 457. The composition of complexes formed in the 429 and 457 boxes (lanes 6 and 10) was further analyzed by
the incorporation of anti-c/EBP  (lanes 7 and 11) and c/EBP  (lanes 8 and 12) antibodies to the binding reaction and compared
with the c/EBP WT sequence (lanes 2–4). The supershifted complexes (lanes 4 and 12) are indicated by a thick arrow and
nonshifted complexes by a thin arrow. Lanes 1, 5, and 9 are controls for free DNA probe. D, Competitive EMSA of the 457 box
using mouse kidney nuclear extracts. Specific protein binding by 32P-labeled oligonucleotide duplex probe 457, incubated with
25 g of nuclear extracts from adult male mouse kidney (lane 2), was competed with the indicated-fold molar excess of cold
c/EBP WT (lanes 3–6) and c/EBP MUT (lanes 7–10) oligonucleotides. Lane 1 represents a control for free DNA probe. The position
of the complexes is indicated by an arrow on the left. E, Supershift assays of complexes bound in box 457 with kidney extracts.
The composition of complexes formed in the 457 box (lane 2) in the presence of mouse kidney extracts was further analyzed by
the incorporation of anti-c/EBP  (lane 3) and c/EBP (lane 4) antibodies to the binding reaction. The supershifted complexes
(lanes 3 and 4) are indicated by thick arrows on the right; a thin arrow marks the position of unshifted complexes. Lane 1
represents a control for free DNA probe.
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Because we already knew that the KClO4 treatment
was effective to render the animals hypothyroid, and
animals in this study presented the same dwarf phe-
notype as before, hormone levels were not measured.
Although both models apparently showed the same
defect, homozygous mice for the recessive hyt muta-
tion exhibited lower cortical expression than controls,
whereas perchlorate-treated animals showed com-
plete absence of KAP mRNA from the early stages of
development (11). In addition, in potassium perchlor-
ate-treated adult males, cortical expression did not
disappear but only decreased (11). In light of these
data, our first hypothesis to explain the differences
between models was that exposure to maternal TH, in
obligated heterozygous hyt/ mothers, was responsi-
ble for priming and enabling KAP cortical response in
adult hyt/hyt males, whereas mice born of mothers
exposed to goitrogen during gestation became unable
to express KAP in adult life. Although the damage
caused by lack of maternal and fetal TH in the devel-
oping brain had been reported (see Ref. 20 for review),
the results of this work do not support the concept that
prenatal TH deprivation is responsible for KAP expres-
sion prevention, but rather demonstrate that its post-
natal presence makes expression possible.
Another distinctive feature between both hypothy-
roidism models was the significant growth failure as-
sociated with perchlorate treatment, which has also
been described in childhood hypothyroidism (21). Hyt
mice, previously used in our laboratory (8), present
slightly lower weight than normal littermates, approx-
imately 20 g, whereas animals under postnatal per-
chlorate treatment are about half the weight, i.e. ap-
proximately 10 g. TH involvement in the regulation of
the rat GH promoter (22), its interaction with retinoic
acid receptors (23) and the participation of cell-spe-
cific transcription factors such as Pit-1/GH factor-1
(24) to fully accomplish GH expression have been
reported.
This observation prompted us to hypothesize that,
although absence of TH diminishes KAP cortical ex-
pression, combined TH and GH deficiency abolishes
it. In situ hybridization analysis performed in the GH-
deficient lit/lit mice (25) and Jackson dwarf mice, de-
ficient in TSH, PRL, and GH due to an inactivating
mutation in the anterior pituitary-specific transcription
factor Pit-1 (26), revealed that GH and TH combined
deficiency does compromise KAP gene expression in
cortical segments in this genetically deficient mouse
model. These results provided further evidence of the
in vivo interactions between GH and T3 for the regu-
lation of KAP gene and, also, that lack of KAP mRNA
was not related to putative undesirable perchlorate
side effects.
This concept was further challenged by administra-
tion of T3, GH or both hormones simultaneously to
perchlorate-treated males on d 7–21. When mice were
euthanized, on postnatal d 40, it became clear that T3
replacement overcomes the inhibitory effects of per-
chlorate and that this effect is even more prominent in
the presence of GH. These results, together with our
previous data (11), strongly support the idea that TH
deprivation without consequences on severe growth
retardation, i.e. in hyt mice and in adult perchlorate-
treated mice, reduces but does not abolish KAP ex-
pression, whereas absence of TH associated with se-
vere growth retardation, i.e. Jackson/dwarf mice and
mice treated postnatally with perchlorate results in
absolute absence of KAP mRNA. Transient transfec-
tion assays from our laboratory had demonstrated that
the KAP promoter enhances its response to andro-
gens by 2.5-fold, in the presence of IGF-I (15). These
data, together with the in vivo results presented in this
work, support the concept that GH can modulate an-
drogen-dependent KAP cortical expression in mouse
kidney.
Although poorly studied in mice, the participation of
TH and GH in gonadal development and puberal mat-
uration has been described in rats (27–31). According
to those studies, the lack of expression of sexual di-
morphic kidney markers such as KAP could, in part, be
related to insufficient androgen levels; nevertheless,
our data indicate that other factors must be involved
because discrete presence of T3 for 48 h anytime after
postnatal d 10, promotes cortical expression of the
gene, when analyzed at postnatal d 40. This time,
which is too short to reprogram gonadal development
in males, might be sufficient to induce one or more
T3/GH-dependent factors required to collaborate with
androgens in KAP expression.
From the in vivo data presented here, we propose
that postnatal expression of KAP mRNA in proximal
convoluted tubules requires the presence of andro-
gens and, also, the contribution of developmentally
regulated factors triggered essentially by T3. Taking
into account the punctual need of T3, we also hypoth-
esize that, after TH priming and in the presence of
some androgen levels, the one or more factors in-
volved in KAP expression must be either autoregu-
lated or under the control of hormones or stimuli other
than T3.
The transcription factors CCAAT/enhancer-binding
proteins (c/EBPs) are members of the bZIP (basic re-
gion leucine zipper) class of DNA-binding proteins.
They play an important role in cellular differentiation
and development (32–36) and fulfill many of the re-
quirements of the hypothesized factor(s) involved in
the regulation of KAP expression in kidney cortex.
Congenital hypothyroidism causes a significant de-
crease in expression of both c/EBP and  isoforms at
early stages of postnatal liver development (17), and
T3 positively regulates c/EBP gene expression
through a functional TH response element found in
c/EBP proximal promoter (37). c/EBP has also been
reported to contribute to regulating c-fos expression
mediated by GH (38). It has recently been reported
that GH promotes relocalization of c/EBP to hetero-
chromatin, in association with the activation of MAPK
signaling, introducing a new level of transcriptional
regulation mediated by this hormone. GH-mediated
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phosphorylation and nuclear redistribution of c/EBP
may be coordinated to achieve spatial-temporal con-
trol of gene expression (39).
Correlation of c/EBP and  levels in nuclear and
cytoplasmic kidney extracts of perchlorate-treated
males with KAP mRNA expression, in contralateral
kidneys of the same animals, showed that, in the
absence of both forms of c/EBP, there is no expres-
sion of KAP. Moreover, T3 injection in perchlorate-
treated males recovers levels of both c/EBPs and
restores KAP expression. Direct evidence of c/EBPs
involvement in KAP transactivation was obtained by
performing transient transfection assays of the KAP
proximal promoter (K638) fused to the CAT reporter
gene in PCT3 cells. This promoter fragment (Fig. 4A)
was selected for transfection because it contains
four putative c/EBP binding sites at positions 66,
110, 429, and 457. Our results showed that
transfection of c/EBP or  (Fig. 4B, lanes 7 and 9)
exerts the same effect on transcriptional activity as
transfection of the AR in the presence of DHT (Fig.
4B, lane 3) and also that simultaneous cotransfec-
tion of  and/or b c/EBPs and AR, in the presence of
androgens, (Fig. 4B, lanes 4–6) produces an additive
effect on K638 transcriptional activity. Altogether,
these results support the concept that the effects of
T3 on the androgenic response of KAP observed in
kidney are, at least in part, mediated by c/EBP and .
Site-directed mutagenesis was performed at spe-
cific sites to elucidate which of the putative c/EBP
binding sites on the promoter were functionally signif-
icant (Fig. 5A). Results (Fig. 4B) indicated that mutation
of individual sites had no effect on promoter activity,
whereas simultaneous mutation of boxes 429 and
457 decreased the transcriptional activity of the pro-
moter approximately 40-fold (Fig. 4C), thereby indicat-
ing that these sites are functionally significant when
they work in a cooperative fashion.
Deprivation of steroid hormones and/or mutation of
the ARE at 39 bp from the transcriptional initiation site
was performed to further investigate whether factors
binding to these functional sites could cooperate with
the androgenic response. The 100- to 150-fold de-
crease in promoter activity obtained in either situation
clearly demonstrated a functional relationship be-
tween transcription factors bound to the 457 and
429 boxes and the AR.
Competitive shift and supershift assays performed
to verify that the 457 and 429 sites were binding-
specific nuclear factors and identify their nature dem-
onstrated that c/EBP and  bind to the457 box but
not to the429. The nature of the factor bound to box
429 remains to be identified. Overall, the data pre-
sented here, together with previous contributions from
our laboratory indicate that expression of the KAP
gene in epithelial cells of proximal convoluted tubules
depends not only on androgens and functional andro-
gen receptors, but also on transcription factors that
bind at boxes 457 and 429 in the proximal pro-
moter. c/EBP and  can bind to the 457 box, ac-
tivate transcription and, together with a third party,
bind to box 429 and trigger expression of the gene
when androgen levels are sufficient in males. After
birth, the presence of TH and GH is required for sexual
maturity and expression of c/EBP and . Once these
factors have been expressed and probably because
they can be autoregulated (40, 41), TH becomes dis-
pensable and cortical KAP expression occurs in the
presence of androgens alone.
Study of the KAP gene has raised the theory that
androgens are necessary, but not sufficient, to ini-
tiate an androgenic response in kidney and that
other developmentally regulated factors, ultimately
controlled by T3, are involved. Studies with the or-
nithine decarboxylase (ODC) gene demonstrate that
the lack of renal androgenic response during the
postnatal period cannot be related only to the low
levels of plasma testosterone at that time, but rather
to immaturity of renal mechanisms to respond to
androgens, which follow a maturational process in
which testosterone could be only one of the factors
implicated (42). Induction of renal ODC by andro-
gens in adult mice requires activation of the trans-
duction cascade mediated by catecholamines bind-
ing to 1-adrenergic receptors (43). Reports
describe the existence of a critical period for T3 to
play a role in development of renal 1-adrenergic
receptors (44); the influence of TH in the develop-
ment of  adrenergic control of ODC in rat kidney
and heart (45) and evidence that c/EBP is required
for transcription of -adrenergic receptors in adi-
pose tissue (46) suggest that c/EBPs under T3 con-
trol might not only be involved in the androgenic
control of KAP gene expression, but rather consti-
tute a more general phenomenon for transcriptional
control of androgen-regulated genes in kidney.
MATERIALS AND METHODS
Materials
Media for cell culture and LIPOFECTAMINE reagent were
obtained from Life Technologies, Inc. (Gaithersburg, MD).
Fetal calf serum, trypsin, glutamine, and essential amino ac-
ids were obtained from Biological Industries (Kibbutz Beit
Haemek, Israel). Other supplements for cell culture, acetyl
coenzyme A, steroid hormones, THs, and thin-layer chroma-
tography plates were obtained from Sigma (St. Louis, MO).
Human GH was a generous gift from Kabi-Pharmacia (Upp-
sala, Sweden). Restriction and modifying enzymes were pur-
chased from either Life Technologies, Inc., Promega (Madi-
son, WI), Amersham Pharmacia Biotech (Amersham,
Buckinghamshire, UK), TaKara Shuzo Co. Ltd. (Shiga, Ja-
pan), or Roche Molecular Biochemicals (Mannheim, Ger-
many). Oligonucleotides were synthesized by TIB MOLBIOL-
Shyntheselabor (Berlin, Germany). All other reagents were
obtained as previously reported (6, 8, 11).
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Animals
Jackson dwarf (strain C3H/HeJ-dw j/dw j), little mice (strain
C57BL/6J-lit/lit) and their genetically matched normal con-
trols (strain C3H/HeJ dw j/ and C57BL/6J-lit/) were ob-
tained at 4–8 wk from The Jackson Laboratory. C57BL/6
control mice were obtained at 6 wk of age from Charles River
Espan˜a (Barcelona, Spain).
Mice were housed in the animal facilities in covered cages
at 22 C with 12 h light and darkness cycles. Pelleted food and
tap water were supplied ad libitum.
At the time of the experiment, animals were euthanized by
cervical dislocation. Kidneys were removed and snap-frozen
immediately in liquid nitrogen in the presence of 2-methylbu-
tane. All animal experimental procedures were conducted in
accordance with Institutional standards which fulfill the re-
quirements established by the Spanish Government and the
European Community (Real Decreto 223/1988: B.O.E. no. 67,
3/18/88) and B.O.E. no. 256, 10/25/90).
Hormone Treatment
T3 hormone was resuspended in 10 mM KOH and 1.2 g/
animal/d were administered sc human GH was reconstituted
with Na2CO3 25 mM (pH 9.4) in 0.9% NaCl and 18 g/
animal/d were injected, sc. Pharmacologically induced con-
genital hypothyroidism was achieved through addition of 1%
KClO4 to drinking water of pregnant dams at d 10 of gesta-
tion. From birth until being euthanized, animals were exposed
to goitrogen, even when other treatments were simulta-
neously performed. The corresponding sham treatments
were effected in all experimental situations. Hypothyroidism
in newborn mice was induced using the same drugs at the
same concentration until the animals were euthanized. When
required, KClO4-treated water was replaced by normal tap
water.
Probe Synthesis and in Situ Hybridization
Histochemistry
35S-Labeled transcripts from pKAP3 or pKAP4 cDNA plas-
mids, which correspond to antisense and sense cRNA, re-
spectively, were prepared as previously described (14). The
preparation of renal sections, hybridization protocol and au-
toradiographic analysis were all performed as reported (8,
11). Hybridized sections were examined under a light micros-
copy. Positive silver grain staining (appearing in black) deter-
mined the site of KAP mRNA synthesis (using KAP3 probe) in
proximal tubule cells. All sections hybridized with the mRNA
KAP4-specific strand sense probe exhibited no detectable
silver grain staining (data not shown).
The magnification chosen for the images shown in the
figures (40) permitted visualization of the three major com-
partments of the kidney (cortex, c; outer medulla, o; inner
medulla, i) and determination of the spatial location of KAP
mRNA. Kidney sections from same figure were each analyzed
in a single experiment. Consequently, slides were exposed to
the same conditions throughout the entire procedure, and
KAP mRNA expression levels on different slides were com-
parable. Photomicrographs shown in the figures were se-
lected from similar results obtained in different experiments
using animals from different litters.
RNA Extraction and Semiquantitative RT-PCR
Total RNA was extracted from kidneys of animals using the
guanidinium thiocyanate method (47). Different amounts of
total RNA were used in each RT-PCR using the SuperScript
One-Step RT-PCR System (Life Technologies, Inc.) under
conditions previously reported. Primer sequences for KAP
and CypA internal control genes have already been described
(15).
Preparation of Protein Extracts and Western Blotting
Kidney tissues were homogenized in buffer A containing 20
mM Tris-HCl (pH 6.8), 50 mM NaCl, 3 mM MgCl2, 300 mM
sucrose; 1% Triton X-100, 2 mM phenylmethanesulfonyl flu-
oride, 10 g/ml aprotinin, 10 g/ml leupeptin, and 1 mM
Na3OV4. Homogenates were centrifuged for 15 min at 13,000
rpm. Supernatant (cytosol and membrane fraction) was
heated at 70 C for 5 min, centrifuged for 20 min at 14,000 rpm
and supernatant (cytosol) frozen at80 C. The pellet from the
original kidney homogenates (including nuclear fraction) was
resuspended in buffer B containing 25 mM Tris-HCl (pH 7.5),
1 mM EGTA, 2 mM EDTA, 1% SDS, and 2 mM phenylmeth-
anesulfonyl fluoride, 10 g/ml aprotinin, 10 g/ml leupeptin,
and 1 mM Na3OV4. The suspension was sonicated until clar-
ified, centrifuged for 15 min at 13,000 rpm and the superna-
tant (nuclear fraction) saved at 80 C. All steps were per-
formed at 4 C. Protein concentration was determined by the
micromethod of Bio-Rad (Hercules, CA) using BSA as a
standard.
Protein extraction from cell cultures was performed using
the same protocol except that, after washing of plates with
PBS, cells were scraped with a rubber policeman and ho-
mogenized with buffer A on a rocking platform for 60 min at
4 C. The remaining procedures were the same as for kidney
extracts.
Fifty micrograms of nuclear and cytosolic proteins from
mouse kidney or cultured cells were size-fractionated by
denaturing 12% SDS-PAGE. Proteins were electroblotted
onto polyvinylidene difluoride membranes (Shleicher &
Schuell, Keene, NH) in transfer buffer (50 mM Tris-HCl, 40 mM
glycine, 20% methanol) and blots blocked overnight at 4 C in
4% BSA in TBST [Tris-HCl 20 mM (pH 7.6), NaCl 130 mM and
Tween 20 at 0.1%]. Primary polyclonal rabbit antibodies anti-
c/EBP (14AA) and anti-c/EBP (C-19) from Santa Cruz Bio-
technologies (Santa Cruz, CA) were diluted at 0.2 mg/ml in
blocking buffer. Washes were performed following the mem-
brane manufacturer’s instructions and secondary antibody
(horseradish peroxidase-conjugated goat antirabbit; Dako
A/S, Glostrup, Denmark) was diluted 1:5000 and incubated
for 1 h at room temperature. After washing, bands were
detected using the ECL chemiluminescence detection
method (Amersham Pharmacia Biotech) and exposed to Hy-
perfilm. To assess specificity of the antibodies, several as-
says were performed using specific blocking peptides (5-fold
excess) (sc-61) for c/EBP, (sc-150 P) for c/EBP and non-
specific (sc-565P) for gp-130, from Santa Cruz
Biotechnologies.
Plasmid Constructs
The strategy for obtaining the promoter fragments consisting
of nucleotides (nt) 224 to 1 and 638 to 1 in the KAP
gene (relative to the transcription start site) has already been
described (15). Constructs were verified by extensive restric-
tion mapping and partial DNA sequencing. All promoter
lengths are available in both CAT and LUC promoterless
vectors. The pCAT-Basic and pGL3-Basic vectors were ob-
tained from Promega Corp. (Madison, WI).
The expression plasmid for -galactosidase pCH110 (Am-
ersham Pharmacia. Biotech) and the Renilla LUC reporter
plasmid pRL-TK (Promega Corp.) were used to normalize
transfection efficiencies of CAT and LUC assays, respec-
tively. Plasmid pSVAR0 containing a simian virus 40 promoter
that directs transcription of the full-length human androgen
receptor cDNA was kindly provided by Dr. C. Lo´pez-Otı´n
(Universidad de Oviedo, Spain) (48). TH receptor, consisting
Teixido et al. • TH Controls Androgen-Regulated Expression of KAP Gene Mol Endocrinol, February 2006, 20(2):389–404 401
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 17 March 2015. at 05:38 For personal use only. No other uses without permission. . All rights reserved.
of cDNA-encoding rat T3R1 cloned in pCDM8, retinoid X
receptor expression vector, human retinoid X receptor 
cDNA cloned in plasmid pSG-5 and the SaltK reporter con-
struct, which corresponds to a TH-responsive element intro-
duced into the reporter plasmid pBLCAT2 upstream of the
heterologous Herpes simplex virus-thymidine kinase pro-
moter, were kindly provided by Dr. A. Mun˜oz (Instituto de
Investigaciones Biome´dicas Alberto Sols, Centro Superior de
Investigaciones Cientificas, Spain) (49). pMSV-c/EBP and
PMSV-c/EBP are expression vectors that contain the entire
open reading frame of rat c/EBP and c/EBP (p35 LAP),
respectively, driven by the murine sarcoma virus promoter
(50). They were kindly provided by Dr. M. Giralt (Universitat de
Barcelona).
Transient Transfection Studies
The cloned PKSV-PCT, referred to as PCT3 cells, has previ-
ously been described (15). The culture conditions have also
been reported (12, 13). Transient transfection experiments
were performed as previously reported (15).
CAT and LUC Assays
These assays were performed as previously reported (15).
Stimulation of CAT and LUC activities were expressed as fold
increase over activities of noninduced transfected cells with
the same reporter plasmids set to 1 and based on at least
three independent experiments.
Site-Directed Mutagenesis of Putative c/EBP
Binding Sites
K224 (110–101), K224 (66–56), K638 (457–448), K638 (429–
420), K638 (110–101), and K638 (66–56) contain deleted pu-
tative c/EBP binding sites of the KAP promoter. K224 and
K638 were used as the DNA mutagenesis template to anneal
with the mutagenic primers. Additional ARE mutation at po-
sition 39 was performed as described (15).
Mutant strands were synthesized with Pfu Turbo DNA
polymerase and used to transform Epicurian Coli XL1-Blue
Supercompetent cells using the QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, Ca). Plasmid DNAs
were isolated from the selection plates and mutants were
identified by sequencing.
EMSA Experiments
Nuclear extracts from PCT3 cells were prepared as described
by Dignam et al (51) without dialysis. Nuclear extracts from
C57BL/6 mice kidney were prepared as described by Land-
schulz et al. (52) starting from 3.5 g of tissue and without
dialysis. For EMSA experiments, the 32P-labeled DNA frag-
ments (C/EBP WT: TGCAGATTGCGCAATCTGCAA, C/EBP
MUT: TGCAGAGACTAGTCTCTGCAA, 429:CTTCACTGTTC-
TCCAGCAATCTGCCAGGAT,457:GATAGTTCTGCTTTTGC-
AATGAGCAGTTCT were incubated with 25 g of kidney
nuclear protein or 5 g of cellular nuclear protein in a binding
buffer [20 mM Tris-HCl (pH 7.4), 75 mM KCl, 0.5% Nonidet
P-40, 10% glycerol, 1 mM DTT] in the presence of 100 ng of
poly(deoxyinosine-deoxycytosine) and 50 ng of acetylated
BSA for 30 min at 37 C in a final volume of 20 l. Oligonu-
cleotide competition experiments were performed under the
same conditions by previous mixing of all the reagents and
increasing amounts of corresponding cold oligonucleotides
before nuclear protein addition. Supershift assays were per-
formed by incubating the complexes for a further 10 min
more at 37 C with anti-C/EBP and anti-C/EBP before
loading. The samples were electrophoresed on 5% acryl-
amide 0.5 TBE gels, dried, and developed with intensifier
screen at 80 C.
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